REDMOND, Wash--NeoPath Inc has signed an agreement with Kaiser
Permanente to install AutoPap 300 QC Systems at its Northern California
facility. Following a successful evaluation, Kaiser Permanente
anticipates making the technology available to its nearly 2.5
million Northern California members.
The AutoPap System rescreens Pap smear slides initially classified
as normal, using high-speed image processing computers, video
imaging technology, and image interpretation software. In clinical
trials in US laboratories, the system improved the detection rate
of false-negative smears.